ClinicalTrials.Veeva

Menu
G

Georgia Clinical Research LLC | Lawrenceville, GA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Lorundrostat
LY3298176
Olpasiran
Avexitide
Mizagliflozin
Plozasiran
PSD502
Tirzepatide
Lofexidine
NOV-001

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 13 total trials

Effect of Mizagliflozin on Hypoglycemia in Patients With Post-Bariatric Hypoglycemia (EMERGE)

VGX-001-013 (EMERGE) is a Phase 2b study to evaluate an investigational new drug, mizagliflozin, for safety, tolerability and its ability to prevent...

Enrolling
Postbariatric Hypoglycemia
Drug: Mizagliflozin 5 mg
Drug: Mizagliflozin 10 mg

The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardi...

Enrolling
Cardiovascular Disease
Drug: Olpasiran
Drug: Placebo

This study is to evaluate the long-term safety, efficacy and tolerability of lorundrostat (an aldosterone synthase inhibitor) in subjects with hypert...

Active, not recruiting
Hypertension
Drug: lorundrostat
Drug: Placebo

Trial sponsors

M
Amgen logo
A
Arrowhead Pharmaceuticals logo
BioMarin Pharmaceutical logo
Lilly logo
N
N
P
Sanofi logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems